Strategic Collaboration between Adaptimmune and Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies Terminated : vimarsana.com

Strategic Collaboration between Adaptimmune and Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies Terminated

Adaptimmune Therapeutics plc , a company redefining the treatment of solid tumor cancers with cell therapy, today announced that its strategic collaboration with Genentech entered in 2021, has been...

Related Keywords

Philadelphia , Pennsylvania , United States , Dana Lynch , Julip Miller , Adrian Rawcliffe , United Kindgom Newsfile Corp , Genentech , Corporate Communications , Exchange Commission , Nasdaq , Corporate Affairs , Chief Executive Officer , Investor Day , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports , Senior Director , Markets ,